NCT04689828 2026-03-23
PSMAfore
Novartis
Phase 3 Active not recruiting
Clinical Trials
12 trialsNCT04720157 2026-03-11
PSMAddition
Novartis
Phase 3 Active not recruiting
NCT07052214 2025-09-10
BiPASS
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3 Recruiting
NCT05547386 2025-07-18
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer
Mayo Clinic
Phase 3 Completed
NCT03582774 2025-05-13
PSMA SRT
Jonsson Comprehensive Cancer Center
Phase 3 Active not recruiting
NCT05847348 2024-07-03
68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3 Recruiting
NCT03001869 2023-11-27
68Ga-PSMA PET/CT in Prostate Cancer
Sir Mortimer B. Davis - Jewish General Hospital
Phase 3 Completed
NCT02659527 2023-06-15
PET/MRI in Patients With Suspected Prostate Cancer
Medical University of Vienna
Phase 3 Completed
NCT05744115 2023-02-24
Ga68-PSMA-11
Harry S. Truman Memorial Veterans' Hospital
Phase 3 Terminated
NCT03353740 2021-10-21
Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence
University of California, San Francisco
Phase 3 Completed
NCT03803475 2021-08-24
Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients
University of California, San Francisco
Phase 3 Completed
NCT02940262 2021-07-02
Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy
Jonsson Comprehensive Cancer Center
Phase 3 Completed